It is known from previous studies that patients with depression experience gut and digestive problems at a higher-than-average rate. If the gut flora of people with depression is transplanted into mice that have been reared in a sterile environment – that is, without any gut flora – the animals also develop depressive behaviour. They appear less energetic and show less interest in their surroundings than their counterparts.
Whether interventions such as taking probiotics to improve the microbiome are beneficial for patients with depression has not yet been sufficiently investigated. Twenty-one patients with confirmed depression at the University Psychiatric Clinics of Basel were therefore given a probiotic for 31 days in addition to their antidepressants, whilst 26 study participants received a placebo plus the antidepressant. Neither the participants nor the study staff knew which preparation the participants were receiving throughout the entire study period. Before treatment, at the end of the month and again four weeks later, the researchers subjected the participants to a series of tests.
The analysis revealed that depressive symptoms decreased in all participants as a result of the antidepressants. However, the condition of the participants in the probiotic group improved significantly more than in the placebo group. In addition, the composition of their gut flora changed: an analysis of stool samples showed an increase in lactic acid bacteria at the end of the treatment; an effect that went hand in hand with the reduction in depressive symptoms. However, once the probiotics were discontinued after around one month, the proportion of health-promoting gut bacteria began to decline steadily again. “It is possible that four weeks of treatment is not long enough and that the new composition of the gut microbiota only stabilises after a longer period,” explains Anna-Chiara Schaub, one of the study’s lead authors.
The therapy is, however, effective, and this is also evident in the processing of emotional stimuli. Another effect of taking probiotics concerned the participants’ brain activity whilst viewing neutral and fearful faces, which was assessed using functional magnetic resonance imaging. In patients with depression, certain regions of the brain behave differently to those in mentally healthy individuals. After four weeks of taking probiotics, this brain activity returned to normal in the participants, but not in the placebo group.
“Further research could help to optimise the selection of bacteria to support treatment for depression,” said study author Schaub: “Although probiotics are not suitable as a stand-alone treatment for depression.”
Reference:
University of Basel
. Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: A randomised controlled trial, Translational Psychiatry 2022, https://www.nature.com/articles/s41398-022-01977-z